Haro Hartounian, head of our biopharma division, will be leading a panel discussion with leaders from Cytiva, GlaxoSmithKline, Amicus Therapeutics and Legend BioTech on the future of Cell & Gene Therapy Manufacturing. We will also …

A 4-day online virtual training course in upstream and downstream processing of viral vectors used in cell and gene therapy. The course will focus on viral vector theory, technical demonstrations of bioreactors, demonstration of chromatography, …

Meet with members of the NJII Biopharma team at this online event where world renowned leaders share the latest analytical techniques & vector technologies.

Join Alex Klarer, Head of Cell Therapy for BioCentriq and speakers from University of Pennsylvania, Nucleus Biologics and Hitachi as they talk about all the variables within your cell culture media and why controlling them …

This event focuses on accelerating Cell and Gene Therapy adoption.

NJII’s Biopharma Division will be presenting at the Alliance for Regenerative Medicine’s Meeting on the Mesa annual conference. If you are interested in getting in touch with them, contact us.

Members of NJII’s Biopharma team plan to participate in the American Society of Gene & Cell Therapy’s Annual meeting. If you are interested in speaking with them, contact us. This festival is one of the leading events spanning the drug development value chain, giving you access to the most inventive scientific minds and business leaders in Boston and around the world.